Impact of Xpert MTB/RIF vs smear microscopy
All‐cause mortality at 6 months (subgroup) · people being investigated for tuberculosis (TB)
Impact of Xpert MTB/RIF probably leads to lower all‐cause mortality in people who were HIV‐positive (subgroup) compared with smear microscopy (moderate certainty).
1 finding from 1 review
- Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis 2021 · Cochrane Headline outcomes onlyOR 0.8 [0.67, 0.96]5 studies · 5855 participantsModerate